APA

Perini P., Facchinetti A., Bulian P., Massaro A. R., Pascalis D. D., Bertolotto A., Biasi G. & Gallo P. (20010531). Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo. : European cytokine network.

Chicago

Perini P, Facchinetti A, Bulian P, Massaro A R, Pascalis D D, Bertolotto A, Biasi G and Gallo P. 20010531. Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo. : European cytokine network.

Harvard

Perini P., Facchinetti A., Bulian P., Massaro A. R., Pascalis D. D., Bertolotto A., Biasi G. and Gallo P. (20010531). Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo. : European cytokine network.

MLA

Perini P, Facchinetti A, Bulian P, Massaro A R, Pascalis D D, Bertolotto A, Biasi G and Gallo P. Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo. : European cytokine network. 20010531.